Centene Corporation

NYSE:CNC

Medical - Healthcare Plans

Healthcare
$67.45 +1.10%

+$0.67 today

Market cap
$33.39B
Beta
1.09
P/E (TTM)
-4.7
EPS (TTM)
-$13.09
52W Low $25.08High $66.55

Volume 6.29M

Average 6.16M

CNC Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

Centene CorporationNYSE: CNC

Selling, General & Admin · Q2 FY2026 · quarter ended Jun 2026

Selling, general & admin grows, but more slowly than its trailing trend

Q2 FY2026 selling, general & admin of $3.1B rose 2.2% year over year, behind the +5.5% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 8.7% from the prior quarter. Over 3 fiscal years it compounded at +4.6% a year.

Context

  • Selling, general & admin amounted to 6.8% of revenue in FY2025, down 0.8 pp from a year earlier.
  • Selling, general & admin increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether selling, general & admin reaches the consensus estimate from 12 analysts of $15.3B (+15.4%) for the fiscal year ending Dec 2026, a step up from the +7.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$3.1B-8.7% QoQ
Last fiscal yearDec 2025
$13.26B+7.0% YoY
LTMJun 2026
$13.37B+5.5% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.2%+14.5%+12.3 pp
1 year+7.0%+15.4%+8.4 pp
3-year CAGR+4.6%+4.7%+0.1 pp
5-year CAGR+4.4%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
13.26B USD
Year-over-year change
+7.0%
4-year CAGR
+8.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How CNC compares with its peers on the latest reported figures

  • CNC's LTM Jun 2026 selling, general & admin of $13.37B is the 2nd highest of the 9 companies compared; the peer median is $5.79B.
  • Its year-over-year change of +5.5% is the 2nd highest of 5, against a peer median of -10.8%.
  • Selling, general & admin amounts to 6.9% of revenue for CNC, versus a peer median of 4.6%.
CNC Competitors Peer median
Selling, General & Admin for CNC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
UNHUnitedHealth Group IncorporatedLTM Sep 2026$15.39B ——3.4%
CNCCentene CorporationLTM Jun 2026$13.37B +5.5%+4.6%6.9%
ELVElevance Health Inc.LTM Sep 2026$12.08B ——6.0%
CICigna CorporationLTM Sep 2026$10.6B -26.1%+2.4%3.7%
HUMHumana Inc.LTM Sep 2026$8.58B ——5.6%
MOHMolina Healthcare, Inc.LTM Sep 2026$3.01B +4.5%+9.2%6.9%
OSCROscar Health, Inc.LTM Jun 2026$1.22B +164.9%+13.0%7.9%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$121.14M -56.9%—2.8%
CVSCVS Health CorporationLTM Jun 2026$0 ——0.0%
Peer median (excluding CNC) $5.79B-10.8%+9.2%4.6%

Competitors are the stored peer set for CNC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue125.98B144.55B154B163.07B194.78B
Cost of Revenue111.78B127.89B136.68B146.24B170.94B
Gross Profit14.2B16.66B17.32B16.83B23.83B
Gross Margin11.3%11.5%11.2%10.3%12.2%
Research & Development00000
Selling, General & Admin9.6B11.59B12.56B12.4B13.26B
Operating Expenses12.42B15.34B14.39B13.65B31.45B
Depreciation & Amortization1.48B1.55B1.29B1.24B1.28B
EBITDA3.95B4.18B5.62B6.2B(5.14B)
EBITDA Margin3.1%2.9%3.6%3.8%-2.6%
Operating Income1.78B1.32B2.93B3.18B(7.62B)
Operating Margin1.4%0.9%1.9%1.9%-3.9%
Interest Income00000
Interest Expense665M665M725M702M678M
Other Income / Expenses29M644M668M1.08B890.41M
Income Before Tax1.81B1.96B3.6B4.26B(6.73B)
Pre-Tax Margin1.4%1.4%2.3%2.6%-3.5%
Income Tax Expense477M760M899M963M(50.96M)
Net Income1.35B1.2B2.7B3.31B(6.67B)
Net Margin1.1%0.8%1.8%2.0%-3.4%
EPS (Basic)2.312.094.976.33(13.61)
EPS (Diluted)2.282.074.956.31(13.62)
Weighted Avg Shares582.83M575.19M543.32M521.79M491.07M
Weighted Avg Shares (Diluted)590.52M582.04M545.7M523.74M491.07M

Centene Corporation

NYSE:CNC

Intrinsic Alpha fair value

Locked

Current Price

$67.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.